Trial intelligence / Profile preview

Remimazolam + Ciprofol to inhibit cough reflex during bronchoscopy in elderly patients

ChiCTR2300079139Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Dec 2023
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of remimazolam and ciprofol (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Incidence of cough reflex. Planned start Dec 2023; status: not yet recruiting.

02

Drugs

remimazolamciprofol

Beyond the preview

Go deeper on ChiCTR2300079139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300079139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call